Pharmacology, Toxicology and Pharmaceutical Science
Absence
16%
Anthelmintic Agent
33%
Antivirus Agent
16%
Bacterium
83%
Chemotherapy
66%
Drug
33%
EC50
100%
Escherichia coli
16%
Homoserine
50%
Human
16%
Infection
16%
Lactone
16%
Malignant Neoplasm
16%
N Acylhomoserine Lactone
66%
Parasitosis
16%
Peptide
16%
Praziquantel
66%
Schistosoma
50%
Schistosoma Mansoni
16%
Schistosomiasis
16%
Schistosomulum
33%
Staphylococcus Aureus
33%
Thiolactone
66%
Trematode
16%
Vaccine
16%
Worm
83%
Medicine and Dentistry
Absence
16%
Adult
33%
Anthelmintic
16%
Anthelmintic Activity
16%
Antimicrobial Activity
33%
Antivirus Agent
16%
Bacterium
83%
Blood
16%
Chemotherapeutic Agent
33%
Development
16%
Drug
33%
Escherichia coli
16%
Evaluation Study
16%
Homoserine
50%
Infection
16%
Lactone
16%
Malignant Neoplasm
16%
N Acylhomoserine Lactone
66%
Neglected Tropical Diseases
33%
Parasitic Disease
16%
Parent
16%
Peptide
16%
Population Density
16%
Praziquantel
66%
Quorum Sensing
50%
Schistosoma Mansoni
16%
Schistosomiasis
16%
Screening
33%
Species
50%
Staphylococcus Aureus
33%
Staphylococcus aureus
16%
Thiolactone
66%
Vaccine
16%
Biochemistry, Genetics and Molecular Biology
Anthelmintic Activity
16%
Antimicrobial Activity
33%
Bacterium
83%
Development
16%
Disease Burden
16%
EC50
100%
Electric Potential
16%
Enantiomer
33%
Escherichia coli
16%
Human
16%
Life
16%
Minimum Inhibitory Concentration
33%
Molecule
16%
Population Density
16%
Quorum Sensing
50%
Schistosoma
50%
Schistosoma Mansoni
16%
Schistosomulum
33%
Screening
33%
Signaling Peptide
16%
Species
50%
Staphylococcus Aureus
33%
Stereoisomerism
33%
Thiolactone
66%
Trematode
16%
Worm
83%
Chemistry
Antihelmintic
16%
Antiinfective
33%
Antimicrobial Agent
33%
Antischistosomal
33%
Density
16%
EC50
100%
Enantiomer
33%
Lactone Ring
16%
MIC
33%
Modification
33%
Molecule
16%
N-Acyl Homoserine Lactone
66%
N-Acylhomoserine
50%
Parasitic
16%
Peptide
16%
Potential
16%
Praziquantel
66%
R
50%
Resistance
16%
Stereoisomer
33%
Thiolactone
66%